Insulin-like growth factor-II renders LIM 2405 human colon cancer cell resistant to butyrate-induced apoptosis: A potential mechanism for colon cancer cell survival in vivo

Carcinogenesis

Volumn 22, Issue 10, 2001, Pages 1625-1631

  Leng, Sweet L ^a   Leeding, Kerri S ^a   Gibson, Peter R ^a   Bach, Leon A ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

4 [5 (4 METHYL 1 PIPERAZINYL)[2,5' BI 1H BENZIMIDAZOL] 2' YL]PHENOL; BUTYRIC ACID; DNA; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 3; TRICHOSTATIN A;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL COUNT; CELL DEATH; CELL MIGRATION; CELL SURVIVAL; COLON CANCER; CONTROLLED STUDY; DRUG EFFECT; DRUG SPECIFICITY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING; TUMOR GROWTH; TUMOR RESISTANCE;

APOPTOSIS; BISBENZIMIDE; BLOTTING, WESTERN; BUTYRATES; CELL MOVEMENT; CELL SURVIVAL; COLONIC NEOPLASMS; DRUG RESISTANCE, NEOPLASM; ENZYME INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HISTONE DEACETYLASES; HUMANS; HYDROXAMIC ACIDS; IMMUNOBLOTTING; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR II; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0034795501     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Short chain fatty acids in the human colon
2. Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man
3. Effect of short-chain fatty acids on paracellular permeability in the Caco-2 model of intestinal epithelium
4. Short-chain fatty acids promote the migration of colonic epithelial cells in vitro
5. Butyrate and the colonocyte. Implications for neoplasia
6. Sodium butyrate induces apoptosis in human colonic tumour cell lines in a p53-independent pathway: Implications for the possible role of dietary fibre in the prevention of large-bowel cancer
7. Potentiation by specific short-chain fatty acids of differential and apoptosis in human colonic carcinoma cell lines
8. Sodium butyrate inhibits carcinoma development in a 1,2-dimethylhydrazine-induced rat colon cancer
9. Butyrate inhibits seeding and growth of colorectal metastases to the liver in mice
10. Resistance to butyrate-induced cell differentiation and apoptosis during spontaneous Caco-2 cell differentiation
11. The effects of insulin-like growth factors on tumorigenesis and neoplastic growth
12. Insulin-like growth factors and cancer
13. Enhanced levels of insulin-like growth factor messenger RNA in human colon carcinomas and liposarcomas
14. Expression of IGF-II and IGF-binding proteins by colon cancer cells in relation to growth responses to IGFs
15. Gene expression profiles in normal and cancer cells
16. Insulin-like growth factor II supply modifies growth of intestinal adenoma in Apc (Min/+) mice
17. Proliferation and differentiation of a human colon cancer cell line (CaCo2) is associated with significant changes in the expression and secretion of insulin-like growth factor (IGF) IGF-II and IGF binding protein-4: Role of IGF-II
18. Insulin-like growth factor binding proteins
19. Insulin-like growth factor-binding protein (IGFBP-3) predisposes breast cancer cells to programmed cell death in a non-IGF-dependent manner
20. Induction of caspase-3 protease activity and apoptosis by butyrate and trichostatin A (inhibitors of histone deacetylase): Dependence on protein synthesis and synergy with a mitochondrial/cytochrome c-dependent pathway
21. Apoptotic death in adenocarcinoma cell lines induced by butyrate and other histone deacetylase inhibitors
22. Role of epidermal growth factor receptor in basal and stimulated colonic epithelial cell migration in vitro
23. Retention of tissue-specific phenotype in a panel of colon carcinoma cell lines: Relationship to clinical correlates
24. An assay for DNA fragmentation in apoptosis without phenol/chloroform extraction and ethanol precipitation
25. The design, expression and characterization of human insulin-like growth factor II (IGF-II) mutants specific for either the IGF-II/cation-independent mannose 6-phosphate receptor or IGF-I receptor
26. HaCaT human keratinocytes express IGF-II, IGFBP-6 and an acid-activated protease with activity against IGFBP-6
27. Direct detection of insulin-like growth factor II (IGF-II) by chemiluminescence without interference by IGF binding proteins
28. The insulin-like growth factor I receptor: A key to tumor growth?
29. Cell-cell contact and specific cytokines inhibit apoptosis of colonic epithelial cells: Growth factors protect against c-myc-independent apoptosis
30. IGF-II and IL-2 act synergistically to alter HDAC1 expression following treatments with trichostatin A
31. IGF-1 regulates cardiac fibroblast apoptosis induced by osmotic stress
32. Expression of insulin-like growth factor (IGF)-II and IGF-I receptor during proliferation and differentiation of CaCo-2 human colon carcinoma cells
33. Blockade of the insulin-like growth-factor-I receptor inhibits growth of human colorectal cancer cells: Evidence of a functional IGF-II-mediated autocrine loop
34. IGF-II/IGF-I receptor pathway upregulates COX-2 mRNA expression and PGE (2) synthesis in Caco-2 human colon carcinoma cells
35. Insulin-like growth factor-I protects colon cancer cells from death factor-induced apoptosis by potentiating tumor necrosis factor α-induced mitogen-activated protein kinase and nuclear factor κB signaling pathways
36. The role of histone acetylation in the allelic expression of the imprinted human insulin-like growth factor II gene
37. IGF-II enhances trichostatin A-induced TGF β1 and p21 (Waf1,Cip1,Sdi1) expression in Hep3B cells
38. Modulating IGFBP-3 expression by trichostatin A: Potential therapeutic role in the treatment of hepatocellular carcinoma
39. Induction of p53-dependent, insulin-like growth factor-binding protein-3-mediated apoptosis in glioblastoma multiforme cells by a protein kinase Cα antisense oligo-nucleotide
40. Histone deacetylases specifically down-regulate p53-dependent gene activation
41. Induction of the growth inhibitor IGF-binding protein 3 by p53
42. Short-chain fatty acids regulate IGF-binding protein secretion by intestinal epithelial cells
43. Protein kinases C-γ and -δ are involved in insulin-like growth factor I-induced migration of colonic epithelial cells
44. Insulin-like growth factors as regulators of cell motility-signaling mechanisms
45. The insulin-like growth factor II (IGF-II)/mannose 6-phosphate receptor mediates IGF-II-induced motility in human rhabdomyosarcoma cells
46. Fibroblast chemotaxis and prolidase activity modulation by insulin-like growth factor II and mannose 6-phosphate
47. Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors